Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjuvant Bevacizumab”

64 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 64 results

Testing effectiveness (Phase 2)Looking for participantsNCT07331883
What this trial is testing

Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Ruijin Hospital 35
Testing effectiveness (Phase 2)Study completedNCT00394251
What this trial is testing

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer

Who this might be right for
Breast Cancer
Celgene 197
Large-scale testing (Phase 3)UnknownNCT04682210
What this trial is testing

Sintilimab Plus Bevacizumab as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Curative Resection

Who this might be right for
HCCAdjuvant TherapyImmunotherapy
Sun Yat-sen University 246
Not applicableActive Not RecruitingNCT07009470
What this trial is testing

A Multicenter, Prospective Study of Perioperative Finotonlimab Combined With Bevacizumab in Resectable Hepatocellular Carcinoma Patients With High-Risk Factors for Recurrence

Who this might be right for
HCC
Tongji Hospital 130
Large-scale testing (Phase 3)Active Not RecruitingNCT02758951
What this trial is testing

Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases

Who this might be right for
Colorectal NeoplasmColorectal CancerColorectal Neoplasms Malignant+8 more
Koen Rovers 358
Large-scale testing (Phase 3)Study completedNCT00884741
What this trial is testing

Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGliosarcomaSupratentorial Glioblastoma
National Cancer Institute (NCI) 637
Testing effectiveness (Phase 2)UnknownNCT01151722
What this trial is testing

Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Diabetic Vitreous Hemorrhage

Who this might be right for
RecurrentHemorrhage
University of Sao Paulo 2
Testing effectiveness (Phase 2)Study completedNCT00200200
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer

Who this might be right for
Hepatic MetastasesColon CancerRectal Cancer
Memorial Sloan Kettering Cancer Center 73
Testing effectiveness (Phase 2)Ended earlyNCT00924209
What this trial is testing

A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer

Who this might be right for
NSCLCStage IIIA (N2)
National Cancer Institute (NCI) 7
Not applicableUnknownNCT06515678
What this trial is testing

Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension

Who this might be right for
Ovarian CancerAntiangiogenic-Associated HypertensionAdjuvant Bevacizumab+1 more
Groupe Hospitalier Pitie-Salpetriere 9,464
Testing effectiveness (Phase 2)Ended earlyNCT00410774
What this trial is testing

Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery

Who this might be right for
Pancreatic Cancer
University of California, San Francisco 20
Large-scale testing (Phase 3)Study completedNCT00887536
What this trial is testing

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 1,613
Not applicableStudy completedNCT00675597
What this trial is testing

Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT01551745
What this trial is testing

Salvage Ovarian FANG™ Vaccine + Bevacizumab

Who this might be right for
Stage III Ovarian CancerStage IV Ovarian Cancer
Gradalis, Inc. 5
Testing effectiveness (Phase 2)Ended earlyNCT00679029
What this trial is testing

Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer

Who this might be right for
HER2-negative Breast CancerStage II Breast CancerStage IIIA Breast Cancer+2 more
University of Nebraska 15
Testing effectiveness (Phase 2)Ended earlyNCT00925652
What this trial is testing

Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 55
Large-scale testing (Phase 3)Study completedNCT01661790
What this trial is testing

Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer

Who this might be right for
Malignant Pleural Effusion
Chinese PLA General Hospital 72
Large-scale testing (Phase 3)Ended earlyNCT00394992
What this trial is testing

Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal Cancer

Who this might be right for
Colorectal CancerLiver Metastases
Dutch Colorectal Cancer Group 79
Large-scale testing (Phase 3)Ended earlyNCT00625898
What this trial is testing

BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab

Who this might be right for
Breast Cancer
NSABP Foundation Inc 3,509
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06958484
What this trial is testing

Iparomlimab and Tuvonralimab Injection (QL1706) Combined With Bevacizumab for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma (HCC) With High Risk of Recurrence

Who this might be right for
HCC - Hepatocellular CarcinomaAdjuvant Treatment
The Affiliated Hospital of Xuzhou Medical University 60
Next Page